How to Buy windlas Shares on Fincept?
You can buy Windlas Biotech Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Windlas Biotech Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Windlas, including updates on board meetings and corporate actions.
Windlas Biotech Limited - https://windlas.com
Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms. It also produces nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprising fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, chewable or dispersible, and plain oral solids. Windlas Biotech Limited was incorporated in 2001 and is based in Gurugram, India.
Windlas Biotech Limited Share Price Today
968.65
OPEN
984.00
HIGH
941.60
LOW
968.35
CLOSE
24 K
VOLUME
2,163 Cr
Market Cap
54672
Average Volume
Healthcare
Sector
NSI
Exchange
Windlas Biotech Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: WINDLAS Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Windlas Biotech Limited |
WINDLAS |
INE0H5O01029 |
Annual General Meeting |
17 Sep 2024 |
5 |
N/A |
Windlas Biotech Limited |
WINDLAS |
INE0H5O01029 |
Dividend - Rs 5.50 Per Share |
17 Sep 2024 |
5 |
N/A |
Windlas Biotech Limited |
WINDLAS |
INE0H5O01029 |
Annual General Meeting/Dividend - Rs 4 Per Share |
05 Sep 2023 |
5 |
N/A |
Windlas Biotech Limited |
WINDLAS |
INE0H5O01029 |
Annual General Meeting/Dividend - Rs 3.50 Per Share |
09 Sep 2022 |
5 |
N/A |
NSE: WINDLAS Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
WINDLAS |
03 Jan 2025, 15:48:42 |
Alteration Of Capital and Fund Raising-XBRL |
N/A |
WINDLAS |
03 Jan 2025, 15:31:28 |
Allotment of Securities |
N/A |
WINDLAS |
03 Jan 2025, 14:01:38 |
General Updates |
N/A |
WINDLAS |
01 Jan 2025, 11:29:27 |
Analysts/Institutional Investor Meet/Con. Call Updates |
N/A |
WINDLAS |
30 Dec 2024, 15:02:27 |
Trading Window-XBRL |
N/A |
NSE: WINDLAS Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Windlas Biotech Limited |
WINDLAS |
18 Oct 2024, 13:02:00 |
18 Oct 2024, 13:02:00 |
|
Windlas Biotech Limited |
WINDLAS |
12 Jul 2024, 16:47:00 |
12 Jul 2024, 16:47:00 |
|
Windlas Biotech Limited |
WINDLAS |
16 Apr 2024, 16:14:00 |
16 Apr 2024, 16:30:00 |
|
Windlas Biotech Limited |
WINDLAS |
17 Jan 2024, 16:00:00 |
17 Jan 2024, 16:30:00 |
|
Windlas Biotech Limited |
WINDLAS |
18 Oct 2023, 15:45:00 |
18 Oct 2023, 16:15:00 |
NSE: WINDLAS Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Independent Director,Chairperson & Non-Executive Director |
21 Dec 1966 |
06 May 2021 |
02826679 |
VIVEK DHARIWAL |
Active |
Executive Director |
23 Oct 1950 |
19 Feb 2001 |
00011451 |
ASHOK KUMAR WINDLASS |
Active |
Executive Director |
06 Jan 1977 |
21 Jan 2008 |
02030941 |
HITESH WINDLASS |
Active |
Executive Director |
24 Sep 1978 |
01 Apr 2006 |
00221671 |
MANOJ KUMAR WINDLASS |
Active |
Executive Director |
02 Jul 1960 |
11 Jun 2019 |
08478261 |
PAWAN KUMAR SHARMA |
Active |
NSE: WINDLAS Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
Board Meeting Intimation |
WINDLAS |
N/A |
INE0H5O01029 |
Windlas Biotech Limited |
05 Nov 2024, 10:26:45 |
WINDLAS BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 13-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 . |
WINDLAS |
N/A |
INE0H5O01029 |
Windlas Biotech Limited |
02 Aug 2024, 13:01:21 |
Financial Results/Dividend |
WINDLAS |
N/A |
INE0H5O01029 |
Windlas Biotech Limited |
10 May 2024, 18:58:41 |
Financial Results |
WINDLAS |
N/A |
INE0H5O01029 |
Windlas Biotech Limited |
30 Jan 2024, 12:41:03 |
Financial Results |
WINDLAS |
N/A |
INE0H5O01029 |
Windlas Biotech Limited |
30 Oct 2023, 12:17:02 |
NSE: WINDLAS Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results |
WINDLAS |
- |
INE0H5O01029 |
Windlas Biotech Limited |
05 Nov 2024, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2024 |
Financial Results |
WINDLAS |
- |
INE0H5O01029 |
Windlas Biotech Limited |
02 Aug 2024, 00:00:00 |
To consider and approve the financial results for the period ended Jun 30, 2024 |
Financial Results/Dividend |
WINDLAS |
- |
INE0H5O01029 |
Windlas Biotech Limited |
10 May 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 and dividend |
Financial Results |
WINDLAS |
- |
INE0H5O01029 |
Windlas Biotech Limited |
30 Jan 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2023 |
Financial Results |
WINDLAS |
- |
INE0H5O01029 |
Windlas Biotech Limited |
30 Oct 2023, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2023 |
NSE: WINDLAS Balance Sheet Data In (Cr)
| date | period_type | Treasury Shares Number | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Non Current Pension And Other Postretirement Benefit Plans | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Deferred Taxes Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Non Current Deferred Taxes Assets | Investmentin Financial Assets | Available For Sale Securities | Long Term Equity Investment | Investmentsin Associatesat Cost | Goodwill And Other Intangible Assets | Other Intangible Assets | Goodwill | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Restricted Cash | Prepaid Assets | Inventory | Other Inventories | Finished Goods | Work In Process | Raw Materials | Other Receivables | Taxes Receivable | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 0.00 | 20,900,311.00 | 20,900,311.00 | 147,770,000.00 | 189,530,000.00 | 4,663,470,000.00 | 4,863,720,000.00 | 2,463,060,000.00 | 4,663,470,000.00 | 37,900,000.00 | 4,712,090,000.00 | 4,712,090,000.00 | 4,712,090,000.00 | 4,712,090,000.00 | 4,607,590,000.00 | 0.00 | 0.00 | 104,500,000.00 | 104,500,000.00 | 2,756,850,000.00 | 47,890,000.00 | 0.00 | 0.00 | 0.00 | 18,580,000.00 | 18,580,000.00 | 0.00 | 28,310,000.00 | 2,708,960,000.00 | 64,490,000.00 | 0.00 | 170,950,000.00 | 19,320,000.00 | 151,630,000.00 | 0.00 | 20,800,000.00 | 1,900,080,000.00 | 0.00 | 0.00 | 20,850,000.00 | 1,879,230,000.00 | 7,468,940,000.00 | 2,296,920,000.00 | 35,150,000.00 | 0.00 | 10,870,000.00 | 55,220,000.00 | 55,220,000.00 | 0.00 | 0.00 | 48,620,000.00 | 48,620,000.00 | 0.00 | 2,147,060,000.00 | 0.00 | 2,147,060,000.00 | 314,740,000.00 | 1,832,320,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5,172,020,000.00 | 334,790,000.00 | 0.00 | 0.00 | 820,060,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,868,250,000.00 | 0.00 | 0.00 | 2,148,920,000.00 | 2,145,060,000.00 | 3,860,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 0.00 | 20,798,575.00 | 20,798,575.00 | 0.00 | 36,410,000.00 | 4,454,680,000.00 | 4,500,450,000.00 | 2,595,350,000.00 | 4,454,680,000.00 | 35,320,000.00 | 4,499,360,000.00 | 4,499,360,000.00 | 4,499,360,000.00 | 4,499,360,000.00 | 48,880,000.00 | 2,259,720,000.00 | 1,950,930,000.00 | 103,990,000.00 | 103,990,000.00 | 1,762,700,000.00 | 45,190,000.00 | 0.00 | 23,210,000.00 | 0.00 | 20,180,000.00 | 20,180,000.00 | 0.00 | 23,210,000.00 | 1,717,510,000.00 | 46,730,000.00 | 0.00 | 16,230,000.00 | 15,140,000.00 | 1,090,000.00 | 7,250,000.00 | 7,250,000.00 | 1,466,490,000.00 | 151,200,000.00 | 180,000.00 | 0.00 | 1,315,110,000.00 | 6,262,060,000.00 | 1,949,200,000.00 | -10,000.00 | 27,810,000.00 | 5,720,000.00 | 16,380,000.00 | 16,380,000.00 | 0.00 | 0.00 | 44,680,000.00 | 44,680,000.00 | 0.00 | 1,851,210,000.00 | -920,600,000.00 | 2,771,810,000.00 | 105,400,000.00 | 58,540,000.00 | 1,605,940,000.00 | 673,320,000.00 | 328,610,000.00 | 0.00 | 4,312,860,000.00 | 262,170,000.00 | 1,110,000.00 | 276,630,000.00 | 621,890,000.00 | 0.00 | 217,510,000.00 | 36,520,000.00 | 367,860,000.00 | 6,660,000.00 | 6,880,000.00 | 1,362,770,000.00 | -36,010,000.00 | 1,398,780,000.00 | 2,043,800,000.00 | 1,990,920,000.00 | 52,880,000.00 | 200,000.00 | 52,680,000.00 |
| 2024-03-31T00:00:00 | annual | 0.00 | 20,798,575.00 | 20,798,575.00 | 0.00 | 36,410,000.00 | 4,454,680,000.00 | 4,500,450,000.00 | 2,595,350,000.00 | 4,454,680,000.00 | 35,320,000.00 | 4,499,360,000.00 | 4,499,360,000.00 | 4,499,360,000.00 | 4,499,360,000.00 | 48,880,000.00 | 2,259,720,000.00 | 1,950,930,000.00 | 103,990,000.00 | 103,990,000.00 | 1,762,700,000.00 | 45,190,000.00 | 0.00 | 23,210,000.00 | 0.00 | 20,180,000.00 | 20,180,000.00 | 0.00 | 23,210,000.00 | 1,717,510,000.00 | 46,730,000.00 | 0.00 | 16,230,000.00 | 15,140,000.00 | 1,090,000.00 | 7,250,000.00 | 7,250,000.00 | 1,466,490,000.00 | 151,200,000.00 | 180,000.00 | 0.00 | 1,315,110,000.00 | 6,262,060,000.00 | 1,949,200,000.00 | -10,000.00 | 27,810,000.00 | 5,720,000.00 | 16,380,000.00 | 16,380,000.00 | 0.00 | 0.00 | 44,680,000.00 | 44,680,000.00 | 0.00 | 1,851,210,000.00 | -920,600,000.00 | 2,771,810,000.00 | 105,400,000.00 | 58,540,000.00 | 1,605,940,000.00 | 673,320,000.00 | 328,610,000.00 | 0.00 | 4,312,860,000.00 | 262,170,000.00 | 1,110,000.00 | 276,630,000.00 | 621,890,000.00 | 0.00 | 217,510,000.00 | 36,520,000.00 | 367,860,000.00 | 6,660,000.00 | 6,880,000.00 | 1,362,770,000.00 | -36,010,000.00 | 1,398,780,000.00 | 2,043,800,000.00 | 1,990,920,000.00 | 52,880,000.00 | 200,000.00 | 52,680,000.00 |
| 2023-09-30T00:00:00 | quarterly | 0.00 | 20,798,575.00 | 20,798,575.00 | 10,840,000.00 | 63,060,000.00 | 4,129,660,000.00 | 4,183,910,000.00 | 2,397,180,000.00 | 4,129,660,000.00 | 40,710,000.00 | 4,161,560,000.00 | 4,162,100,000.00 | 4,161,560,000.00 | 4,161,560,000.00 | 4,057,570,000.00 | 0.00 | 0.00 | 103,990,000.00 | 103,990,000.00 | 1,538,610,000.00 | 51,380,000.00 | 0.00 | 0.00 | 0.00 | 25,550,000.00 | 25,010,000.00 | 540,000.00 | 23,430,000.00 | 1,487,230,000.00 | 25,100,000.00 | 0.00 | 37,510,000.00 | 15,700,000.00 | 21,810,000.00 | 0.00 | 10,330,000.00 | 1,085,250,000.00 | 0.00 | 0.00 | 13,300,000.00 | 1,071,950,000.00 | 5,700,170,000.00 | 1,815,760,000.00 | 117,530,000.00 | 0.00 | 19,250,000.00 | 24,460,000.00 | 24,460,000.00 | 0.00 | 0.00 | 31,900,000.00 | 31,900,000.00 | 0.00 | 1,622,620,000.00 | 0.00 | 1,622,620,000.00 | 569,530,000.00 | 1,053,090,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,884,410,000.00 | 292,780,000.00 | 0.00 | 0.00 | 610,930,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,274,020,000.00 | 0.00 | 0.00 | 1,706,680,000.00 | 1,695,170,000.00 | 11,510,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 867,747.00 | 20,926,628.00 | 21,794,375.00 | 0.00 | 49,930,000.00 | 4,007,870,000.00 | 4,027,150,000.00 | 2,322,940,000.00 | 4,007,870,000.00 | 45,490,000.00 | 4,022,710,000.00 | 4,023,800,000.00 | 4,022,710,000.00 | 4,022,710,000.00 | 28,210,000.00 | 1,763,460,000.00 | 1,990,520,000.00 | 104,630,000.00 | 104,630,000.00 | 1,267,040,000.00 | 54,620,000.00 | 0.00 | 20,180,000.00 | 0.00 | 31,260,000.00 | 30,170,000.00 | 1,090,000.00 | 20,180,000.00 | 1,212,420,000.00 | 41,460,000.00 | 5,910,000.00 | 18,670,000.00 | 15,320,000.00 | 3,350,000.00 | 4,480,000.00 | 4,480,000.00 | 991,130,000.00 | 113,700,000.00 | 0.00 | 5,910,000.00 | 877,430,000.00 | 5,289,750,000.00 | 1,754,390,000.00 | 415,920,000.00 | 46,400,000.00 | 20,250,000.00 | 52,440,000.00 | 52,440,000.00 | 0.00 | 0.00 | 14,840,000.00 | 14,840,000.00 | 0.00 | 1,614,720,000.00 | -815,140,000.00 | 2,429,860,000.00 | 525,720,000.00 | 37,360,000.00 | 988,420,000.00 | 549,750,000.00 | 328,610,000.00 | 0.00 | 3,535,360,000.00 | 285,020,000.00 | 550,000.00 | 294,770,000.00 | 747,380,000.00 | 0.00 | 170,390,000.00 | 179,520,000.00 | 397,470,000.00 | 4,380,000.00 | 0.00 | 1,168,600,000.00 | -33,920,000.00 | 1,202,520,000.00 | 1,319,680,000.00 | 1,282,820,000.00 | 36,860,000.00 | 0.00 | 36,860,000.00 |
| 2023-03-31T00:00:00 | annual | 867,747.00 | 20,926,628.00 | 21,794,375.00 | 0.00 | 49,930,000.00 | 4,007,870,000.00 | 4,027,150,000.00 | 2,322,940,000.00 | 4,007,870,000.00 | 45,490,000.00 | 4,022,710,000.00 | 4,023,800,000.00 | 4,022,710,000.00 | 4,022,710,000.00 | 28,210,000.00 | 1,763,460,000.00 | 1,990,520,000.00 | 104,630,000.00 | 104,630,000.00 | 1,267,040,000.00 | 54,620,000.00 | 0.00 | 20,180,000.00 | 0.00 | 31,260,000.00 | 30,170,000.00 | 1,090,000.00 | 20,180,000.00 | 1,212,420,000.00 | 41,460,000.00 | 5,910,000.00 | 18,670,000.00 | 15,320,000.00 | 3,350,000.00 | 4,480,000.00 | 4,480,000.00 | 991,130,000.00 | 113,700,000.00 | 0.00 | 5,910,000.00 | 877,430,000.00 | 5,289,750,000.00 | 1,754,390,000.00 | 415,920,000.00 | 46,400,000.00 | 20,250,000.00 | 52,440,000.00 | 52,440,000.00 | 0.00 | 0.00 | 14,840,000.00 | 14,840,000.00 | 0.00 | 1,614,720,000.00 | -815,140,000.00 | 2,429,860,000.00 | 525,720,000.00 | 37,360,000.00 | 988,420,000.00 | 549,750,000.00 | 328,610,000.00 | 0.00 | 3,535,360,000.00 | 285,020,000.00 | 550,000.00 | 294,770,000.00 | 747,380,000.00 | 0.00 | 170,390,000.00 | 179,520,000.00 | 397,470,000.00 | 4,380,000.00 | 0.00 | 1,168,600,000.00 | -33,920,000.00 | 1,202,520,000.00 | 1,319,680,000.00 | 1,282,820,000.00 | 36,860,000.00 | 0.00 | 36,860,000.00 |
| 2022-03-31T00:00:00 | annual | 0.00 | 21,794,375.00 | 21,794,375.00 | 55,510,000.00 | 66,370,000.00 | 3,938,950,000.00 | 4,008,980,000.00 | 2,876,650,000.00 | 3,938,950,000.00 | 5,160,000.00 | 3,947,770,000.00 | 3,952,210,000.00 | 3,947,770,000.00 | 3,947,770,000.00 | 18,130,000.00 | 1,415,040,000.00 | 2,269,470,000.00 | 108,970,000.00 | 108,970,000.00 | 962,340,000.00 | 22,480,000.00 | 40,000.00 | 15,660,000.00 | 0.00 | 4,440,000.00 | 0.00 | 4,440,000.00 | 0.00 | 939,860,000.00 | 15,040,000.00 | 0.00 | 61,930,000.00 | 5,160,000.00 | 56,770,000.00 | 3,300,000.00 | 0.00 | 707,540,000.00 | 75,220,000.00 | 0.00 | 0.00 | 632,320,000.00 | 4,910,110,000.00 | 1,093,600,000.00 | 20,000.00 | 55,660,000.00 | 20,350,000.00 | 23,140,000.00 | 23,140,000.00 | 0.00 | 0.00 | 8,820,000.00 | 8,820,000.00 | 0.00 | 983,150,000.00 | -695,050,000.00 | 1,678,200,000.00 | 75,810,000.00 | 36,410,000.00 | 854,050,000.00 | 481,200,000.00 | 230,730,000.00 | 0.00 | 3,816,510,000.00 | -10,000.00 | 1,560,000.00 | 312,300,000.00 | 587,100,000.00 | 10,000.00 | 130,890,000.00 | 66,350,000.00 | 389,850,000.00 | 22,130,000.00 | 40,960,000.00 | 1,107,720,000.00 | -11,170,000.00 | 1,118,890,000.00 | 1,785,710,000.00 | 1,780,010,000.00 | 5,700,000.00 | 1,820,000.00 | 3,880,000.00 |
| 2021-03-31T00:00:00 | annual | 0.00 | 21,794,375.00 | 21,794,375.00 | 153,860,000.00 | 323,490,000.00 | 1,986,370,000.00 | 2,304,350,000.00 | 1,008,920,000.00 | 1,986,370,000.00 | 10,330,000.00 | 1,991,190,000.00 | 1,999,510,000.00 | 1,991,190,000.00 | 1,991,190,000.00 | 0.00 | 1,035,950,000.00 | 754,910,000.00 | 64,110,000.00 | 64,110,000.00 | 970,040,000.00 | 35,850,000.00 | 0.00 | 13,730,000.00 | 6,830,000.00 | 13,490,000.00 | 5,170,000.00 | 8,320,000.00 | 0.00 | 934,190,000.00 | 0.00 | 0.00 | 310,000,000.00 | 5,160,000.00 | 304,840,000.00 | 2,820,000.00 | 0.00 | 484,500,000.00 | 85,170,000.00 | 0.00 | 0.00 | 399,330,000.00 | 2,961,230,000.00 | 1,018,120,000.00 | 0.00 | 56,620,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4,820,000.00 | 4,820,000.00 | 0.00 | 956,680,000.00 | -580,970,000.00 | 1,537,650,000.00 | 2,100,000.00 | 34,800,000.00 | 790,680,000.00 | 479,340,000.00 | 230,730,000.00 | 0.00 | 1,943,110,000.00 | 12,740,000.00 | 2,860,000.00 | 174,910,000.00 | 414,610,000.00 | 0.00 | 64,370,000.00 | 85,450,000.00 | 264,790,000.00 | 1,310,000.00 | 0.00 | 794,130,000.00 | -7,700,000.00 | 801,830,000.00 | 542,550,000.00 | 383,250,000.00 | 159,300,000.00 | 118,110,000.00 | 41,190,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 93,530,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,330,000.00 | 940,010,000.00 | 940,010,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: WINDLAS Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Repurchase Of Capital Stock | Repayment Of Debt | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Other Cash Adjustment Outside Changein Cash | Beginning Cash Position | Changes In Cash | Financing Cash Flow | Interest Paid Cff | Cash Dividends Paid | Net Common Stock Issuance | Common Stock Payments | Common Stock Issuance | Net Issuance Payments Of Debt | Net Short Term Debt Issuance | Net Long Term Debt Issuance | Long Term Debt Payments | Investing Cash Flow | Interest Received Cfi | Net Investment Purchase And Sale | Sale Of Investment | Purchase Of Investment | Net Business Purchase And Sale | Sale Of Business | Purchase Of Business | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Liabilities | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Stock Based Compensation | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Gain Loss On Investment Securities | Net Foreign Currency Exchange Gain Loss | Gain Loss On Sale Of PPE | Gain Loss On Sale Of Business | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 712,760,000.00 | -40,230,000.00 | -1,090,000.00 | 0.00 | -376,840,000.00 | 52,880,000.00 | 0.00 | 36,860,000.00 | 16,020,000.00 | -152,900,000.00 | -11,070,000.00 | -83,010,000.00 | -40,230,000.00 | -40,230,000.00 | 0.00 | -3,350,000.00 | -2,260,000.00 | -1,090,000.00 | -1,090,000.00 | -920,680,000.00 | 17,410,000.00 | -561,670,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -376,420,000.00 | 420,000.00 | -376,840,000.00 | 1,089,600,000.00 | -186,480,000.00 | 439,530,000.00 | 52,080,000.00 | 17,650,000.00 | 437,680,000.00 | 125,490,000.00 | -198,350,000.00 | -8,640,000.00 | 20,670,000.00 | 27,490,000.00 | 134,440,000.00 | 2,460,000.00 | 131,980,000.00 | -108,210,000.00 | -50,000.00 | -60,000.00 | 0.00 | 770,910,000.00 |
| 2023-03-31T00:00:00 | annual | -99,250,000.00 | -271,930,000.00 | -3,350,000.00 | 0.00 | -708,900,000.00 | 36,860,000.00 | 0.00 | 5,700,000.00 | 31,160,000.00 | -437,390,000.00 | -7,870,000.00 | -76,280,000.00 | -271,930,000.00 | -271,930,000.00 | 0.00 | -56,770,000.00 | -53,420,000.00 | -3,350,000.00 | -3,350,000.00 | -141,100,000.00 | 45,500,000.00 | 513,200,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -699,800,000.00 | 9,100,000.00 | -708,900,000.00 | 609,650,000.00 | -97,160,000.00 | 63,200,000.00 | 65,990,000.00 | -9,700,000.00 | 245,120,000.00 | -160,280,000.00 | -83,630,000.00 | -26,480,000.00 | 10,080,000.00 | 22,750,000.00 | 123,640,000.00 | 1,980,000.00 | 121,660,000.00 | -47,820,000.00 | -270,000.00 | -8,760,000.00 | 0.00 | 570,390,000.00 |
| 2022-03-31T00:00:00 | annual | -56,740,000.00 | 0.00 | -3,880,000.00 | 1,650,000,000.00 | -148,040,000.00 | 5,700,000.00 | 0.00 | 159,300,000.00 | -153,600,000.00 | 1,300,880,000.00 | -14,150,000.00 | 0.00 | 1,650,000,000.00 | 0.00 | 1,650,000,000.00 | -251,950,000.00 | -248,070,000.00 | -3,880,000.00 | -3,880,000.00 | -1,545,780,000.00 | 25,620,000.00 | -1,424,460,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -146,940,000.00 | 1,100,000.00 | -148,040,000.00 | 91,300,000.00 | -88,800,000.00 | -375,680,000.00 | 15,180,000.00 | -137,090,000.00 | 233,040,000.00 | -172,490,000.00 | -316,730,000.00 | -25,550,000.00 | 18,130,000.00 | 3,480,000.00 | 121,470,000.00 | 2,210,000.00 | 119,260,000.00 | -17,240,000.00 | -60,000.00 | -100,000.00 | 0.00 | 455,650,000.00 |
| 2021-03-31T00:00:00 | annual | 56,070,000.00 | 0.00 | -45,750,000.00 | 0.00 | -58,470,000.00 | 159,300,000.00 | 58,200,000.00 | 180,780,000.00 | -79,680,000.00 | 7,760,000.00 | -13,650,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 38,850,000.00 | 84,600,000.00 | -45,750,000.00 | -45,750,000.00 | -201,980,000.00 | 16,620,000.00 | 874,720,000.00 | 1,022,150,000.00 | -147,430,000.00 | -1,035,000,000.00 | 0.00 | -1,035,000,000.00 | -58,320,000.00 | 150,000.00 | -58,470,000.00 | 114,540,000.00 | -65,320,000.00 | -400,390,000.00 | 64,610,000.00 | 53,040,000.00 | -460,390,000.00 | 100,700,000.00 | -153,740,000.00 | -3,440,000.00 | 0.00 | 10,620,000.00 | 129,650,000.00 | 4,990,000.00 | 124,660,000.00 | -5,750,000.00 | -30,000.00 | -90,000.00 | -56,470,000.00 | 217,400,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 360,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: WINDLAS Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Minority Interests | Net Income Including Noncontrolling Interests | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Write Off | Net Non Operating Interest Income Expense | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Research And Development | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 2.65 | 0.00 | 80.81 | 10.83 | 10.83 | 58.19 | 13.44 | 396.18 | 91.64 | 78.20 | 0.86 | 1.11 | 1.97 | 50.01 | 58.19 | 564.16 | 0.49 | 2.09 | 2.08 | 0.00 | 0.00 | 58.19 | 58.19 | 0.00 | 58.19 | 0.00 | 58.19 | 58.19 | 18.90 | 77.09 | 0.35 | 0.01 | -0.01 | 0.00 | 0.86 | 1.11 | 1.97 | 64.73 | 167.98 | 34.85 | 13.44 | 0.25 | 13.20 | 7.88 | 25.84 | 22.11 | 3.74 | 0.49 | 232.71 | 396.18 | 628.89 | 628.89 |
| 2023-03-31T00:00:00 | annual | 1.41 | 0.00 | 64.60 | 5.60 | 5.60 | 42.63 | 12.36 | 325.45 | 70.19 | 57.83 | 2.70 | 0.79 | 3.49 | 38.44 | 42.63 | 462.66 | 0.39 | 2.16 | 2.16 | 0.00 | 0.00 | 42.63 | 42.63 | 0.00 | 42.63 | 0.00 | 42.63 | 42.63 | 14.41 | 57.04 | 0.44 | 0.81 | -0.88 | 0.06 | 2.70 | 0.79 | 3.49 | 47.92 | 137.21 | 28.91 | 12.36 | 0.20 | 12.17 | 8.95 | 18.61 | 14.60 | 4.01 | 0.39 | 185.13 | 325.45 | 510.58 | 510.58 |
| 2022-03-31T00:00:00 | annual | 0.25 | 0.00 | 57.58 | 1.55 | 1.55 | 38.09 | 12.15 | 302.82 | 59.13 | 46.98 | 2.87 | 1.42 | 4.29 | 36.79 | 38.09 | 422.78 | 0.44 | 2.05 | 2.05 | 0.00 | 0.00 | 38.09 | 38.09 | 0.00 | 38.09 | 0.00 | 38.09 | 38.09 | 7.48 | 45.57 | 0.08 | -0.30 | -0.01 | 0.31 | 2.87 | 1.42 | 4.29 | 40.59 | 119.97 | 24.37 | 12.15 | 0.22 | 11.93 | 6.51 | 15.45 | 10.68 | 4.77 | 0.44 | 160.56 | 302.82 | 463.37 | 463.37 |
| 2021-03-31T00:00:00 | annual | -6.63 | 0.00 | 32.08 | 3.92 | -23.35 | 15.83 | 12.97 | 274.41 | 36.00 | 23.03 | 0.63 | 1.29 | 1.92 | 59.82 | 15.83 | 382.39 | 0.04 | 3.26 | 1.82 | 0.00 | 0.00 | 15.83 | 15.83 | 0.00 | 15.83 | 0.26 | 15.57 | 15.57 | 6.17 | 21.74 | 0.20 | -23.92 | -5.66 | 2.31 | 0.63 | 1.29 | 1.92 | 44.33 | 107.98 | 21.94 | 12.97 | 0.50 | 12.47 | 3.61 | 11.94 | 8.39 | 3.55 | 0.04 | 152.31 | 274.41 | 426.71 | 426.71 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
29.19
P/E
35.45221
P/B
4.7836637
Dividend Yield
0.54%
Market Cap
2,163.29 Cr.
Face Value
216.33
Book Value
216.33
ROE
9.01%
EBITDA Growth
79.54 Cr.
Debt/Equity
0.809
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of windlas?
The market capitalization of Windlas Biotech Limited is ₹2,163 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Windlas Biotech Limited?
The PE and PB ratios of Windlas Biotech Limited are Not Available and 4.7836637 respectively as of 05 Feb 2025.
What is the 52 Week High of Windlas Biotech Limited?
The 52-week high of Windlas Biotech Limited is ₹1198.25 as of 05 Feb 2025.
What is the 52 Week Low of Windlas Biotech Limited?
The 52-week low of Windlas Biotech Limited is ₹423.45 as of 05 Feb 2025.
What are the earnings per share (EPS) for Windlas Biotech Limited?
The Earnings Per Share (EPS) of Windlas Biotech Limited is ₹29.19 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Windlas Biotech Limited?
The Return on Equity (ROE) of Windlas Biotech Limited is 9.01% as per the most recent financial year data. Explore more on Fincept.